Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.

Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.

Loomba R, Ratziu V, Harrison SA; NASH Clinical Trial Design International Working Group. Gastroenterology. 2021 Nov 22:S0016-5085(21)03795-1. doi: 10.1053/j.gastro.2021.10.051.

in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?